G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/574 (2006.01) G01N 33/543 (2006.01)
Patent
CA 2483352
The present invention relates to the treatment of cancer with compounds that inhibit the activity of endo-exonuclease. Endo-exonuclease has been shown to be necessary for the repair of damaged DNA. Compounds that inhibit the activity of endo-exonuclease have been shown to be particularly effective for treating cancer when used in combination with drugs that induce DNA breaks such as cisplatin and mitomycin C. These compounds have a synergistic effect when used in combination for inhibiting tumour growth. The invention includes pharmaceutical compositions for inhibiting tumour growth comprising a compound that inhibits endo-exonuclease activity. These pharmaceutical compositions preferably include compounds that induce DNA breaks. The invention includes methods of treating cancer with these pharmaceutical compositions and uses of these compositions to treat cancer. The preferred compounds that inhibit the activity of endo-exonuclease have low toxicity. One such compound is pentamidine. The invention also includes a method for diagnosing cancer and monitoring its progression. This aspect of the invention involves isolating serum from a patient; measuring the concentration of endo-exonuclease in said serum and determining whether said concentration is above a predetermined mean.
Chow Terry
Griller David
Yeh Chiaoli
Yuen Leonard
Dimock Stratton Llp
Oncozyme Pharma Inc
LandOfFree
Inhibitors of endo-exonuclease activity for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of endo-exonuclease activity for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of endo-exonuclease activity for treating cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1361039